Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $65
Alkermes Public Limited Company
Alkermes Public Limited Company ALKS | 0.00 |
Piper Sandler analyst David Amsellem reiterates Alkermes (NASDAQ:
ALKS) with a Overweight and raises the price target from $43 to $65.